“Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors”. Radiology and Oncology 54, no. 4 (November 13, 2020): 480–487. Accessed October 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/3439.